A carregar...
Interleukin-6 identified as an important factor in hypoxia- and aldehyde dehydrogenase-based gefitinib adaptive resistance in non-small cell lung cancer cells
Gefitinib resistance and relapse of the disease were the greatest challenges facing clinical therapy of non-small-cell lung cancer (NSCLC). Of note, regarding the hypoxia condition in solid tumor tissues in vivo, roles of hypoxia in gefitinib adaptive resistance and its association with lung cancer...
Na minha lista:
Publicado no: | Oncol Lett |
---|---|
Main Authors: | , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
D.A. Spandidos
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5588073/ https://ncbi.nlm.nih.gov/pubmed/28927099 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6613 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|